ETC-1002 40 , 80 , and 120 mg lowered least-squares mean SE LDL-C levels by 17.9 2.2 % , 25.0 2.1 % , and 26.6 2.2 % , respectively , versus a reduction of 2.1 2.2 % with placebo ( all , p < 0.0001 ) ; LDL-C lowering was similar between the subgroups with nonelevated and elevated triglycerides .
